Purchase Order HHSN261201700657P

Award Date 9/18/17
Potential Completion Date 9/17/18
Potential Value $60K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $124,452 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Harvard T.H. Chan School of Public Health. The contract is for the continued application of statistical methods and standardization of circulating vitamin D data from 21 cohorts in the Pooling Project of Breast and Colorectal Cancer. This contract does not have a set-aside designation. Through federal contract and grant awards, Harvard T.H. Chan School of Public...
The National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $1,903,737.98 definitive cost-no-fee contract to Brigham & Women's Hospital in Boston, Massachusetts. The contract is for a Phase II clinical trial of celecoxib for the prevention of sporadic colorectal adenomas, with Dr. Monica Bertagnolli serving as the Principal Investigator and Dr. Asad Umar as the Contracting Officer's Technical Representative. The contract does...
This federal contract award was issued by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to the University of Massachusetts Medical School (UMMS) for the "CONTINUATION OF FOLLOW-UP OF DES-EXPOSED COHORTS" project. The $1,485,274.31 contract is a definitive cost-no-fee contract and does not have a set-aside designation. Under this award, UMMS is the prime contractor managing the overall study, which involves long-term follow-up of cohorts...
This is a $97,457 firm-fixed price purchase order awarded by the National Cancer Institute (NCI) to the Department of Public Health Connecticut for the NCI Patterns of Care Study focused on diagnosis year 2020 breast and colorectal cancer cases. The study aims to collect data on biomarker testing, targeted therapies, adjuvant treatments, and the impact of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and supportive/palliative care. It involves a stratified random sample of...
This firm-fixed price purchase order for $241,990 was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to The Trustees of Columbia University in the City of New York. The contract supports large-scale data analysis to characterize variations in cancer treatments across the United States to assist the NCI's Division of Cancer Control and Population Sciences. The prime contractor, Columbia University, is...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to President And Fellows Of Harvard College, doing business as Harvard Medical School, for a project titled "MODELING SEX-SPECIFIC RADIATION AND CHEMOTHERAPY RESPONSES IN A BONE MARROW CHIP". The contract has a potential value of $398,677.00 and a completion date of April 15, 2019. The contract is for research and development services and is not set aside for any specific...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $103,000 firm fixed price delivery order contract to Metabolon, Inc. for assessing the physiologic impact of long-term multivitamin use and metabolite stability using repeated metabolomic measures. This contract is being performed under the agency's Metabolomic Profiling for Molecular Epidemiology Studies program. As the prime contractor, Metabolon will utilize repeated metabolomic...
The National Institutes of Health's National Institute of Environmental Health Sciences awarded a $3.7 million cost-reimbursement task order to Social & Scientific Systems, Inc. to support the Investigation of Vitamin D and Menstrual Cycles Trial. Under this non-severable delivery order issued against the NIH's Support Services for Epidemiology contract vehicle, SSS will assist the NIEHS with the clinical trial examining the relationship between vitamin D levels and menstrual cycles over a...
The National Cancer Institute (NCI) awarded a $87,431.00 firm fixed price purchase order to the University of New Mexico (UNM) Health Sciences Center to collect data for the NCI Patterns of Care Study, focusing on breast and colorectal cancer cases diagnosed in 2020. This study aims to describe the use of recommended biomarker tests, targeted therapies, and other adjuvant treatments, as well as document the effects of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, a $126,602.75 firm fixed price purchase order contract for the "EFFICIENT CONDUCT OF LARGE-SCALE OBSERVATIONAL STUDIES IN CANCER" on August 29, 2017. The contract does not have a set-aside designation and is scheduled for completion on April 4, 2022. As a major research...

HARVARD UNIV: EXPANDED ANALYSES OF CIRCULATING VITAMIN D AND RISK OF COLORECTAL AND BREAST CANCER BY CANCER SUBTYPES AND IN POPULATION SUBGROUPS

Posted 9/18/17, 12:00 AM